Lingxiang Liu
Overview
Explore the profile of Lingxiang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou Z, Qin P, Cheng X, Shao M, Ren Z, Zhao Y, et al.
Curr Oncol Rep
. 2025 Feb;
PMID: 39998782
Purpose Of Review: This study aims to systematically review the trajectory of artificial intelligence (AI) development in the medical field, with a particular emphasis on ChatGPT, a cutting-edge tool that...
2.
Feng Q, Sun Y, Yang Z, Wang Z, Chen Z, Liu F, et al.
Front Oncol
. 2025 Jan;
14():1522919.
PMID: 39850821
Copper, an essential trace element and biochemical cofactor in humans plays a critical role in maintaining health. Recent studies have identified a significant association between copper levels and the progression...
3.
Zhao T, Zhao H, Zhang X, Jiang X, Liang Q, Ni S, et al.
BMC Cancer
. 2024 Nov;
24(1):1456.
PMID: 39592977
Background: Cancer survivors face many challenges in long-term health management, including malnutrition, systemic inflammation, and sleep issues, which significantly affect their survival and quality of life. Methods: A prospective cohort...
4.
Zhao T, Zhang X, Liu X, Jiang X, Chen S, Li H, et al.
J Gastrointest Oncol
. 2024 Nov;
15(5):2129-2144.
PMID: 39554569
Background: PANoptosis is a cell death pathway involved in pyroptosis, apoptosis and necrosis, and plays a key role in the development of malignant tumors. However, the molecular signature of PANoptosis...
5.
Bao H, Bao H, Lin L, Wang Y, Zhang L, Zhang L, et al.
PeerJ
. 2024 Sep;
12:e18065.
PMID: 39282115
Background: Although chemoradiotherapy is an effective treatment for esophageal cancer, its feasibility in esophageal cancer with cirrhosis remains largely unclear. Methods: We retrospectively studied 11 patients with superficial esophageal cancer...
6.
Ni S, Liang Q, Jiang X, Ge Y, Jiang Y, Liu L
Heliyon
. 2024 Apr;
10(8):e29840.
PMID: 38681577
The introduction of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of lung cancer. Given the limited clinical benefits of immunotherapy in patients with non-small cell lung cancer (NSCLC), various...
7.
Jiang X, Wang S, Liang Q, Liu Y, Liu L
Med Oncol
. 2023 Dec;
41(1):35.
PMID: 38151631
The epithelial cell adhesion molecule (EpCAM) is a critical glycoprotein involved in cell cycle progression, proliferation, differentiation, migration, and immune evasion. Its role as a target for bispecific antibodies has...
8.
Wang S, Chen S, Li H, Ben S, Zhao T, Zheng R, et al.
J Biomed Res
. 2023 Dec;
38(1):37-50.
PMID: 38111199
The interplay between DNA replication stress and immune microenvironment alterations is known to play a crucial role in colorectal tumorigenesis, but a comprehensive understanding of their association with and relevant...
9.
Jiang X, Liang Q, Xu H, Gu S, Liu L
Comput Math Methods Med
. 2022 Oct;
2022:2492488.
PMID: 36245841
Aims: This paper aims to investigate the relationship of waist circumference (WC) with digestive tract cancer morbidity and mortality. Methods: Based on the data from a nationally representative US population...
10.
Zheng R, Zhang K, Tan S, Gao F, Zhang Y, Xu W, et al.
Mol Cancer
. 2022 Feb;
21(1):49.
PMID: 35164758
Background: Exosomes have emerged as vital biomarkers of multiple cancers and contain abundant circular RNAs (circRNAs). However, the potential for exosomal circRNAs to be used in diagnostics and their molecular...